Abstract
Objective To identify barriers (patient, provider, practice, and system levels) to consider when implementing patient experience surveys in Australian general practice, and enablers of their systematic use to inform service improvement in clinical practice as well as the broader health system. Methods and Analysis An expert consultation and qualitative content analysis of cross-sectional, open-text survey data. Data was collected from key international and Australian experts in the areas of measurement and quality improvement in general practice. Results Participants discussed the importance of ensuring value and relevance of surveys to stakeholders. Lack of resources, IT infrastructure, capacity building, and sustained funding were identified as barriers to implementing surveys. Participants discussed the importance of clearly defining and communicating the purpose of surveys and agreed on the value of using patient experience to inform reflective, team-based learning at the practice level. Opinions differed on the use of patient experience data at the system-level, with some questioning its utility or fairness for external performance reporting. Others recommended the aggregation and reporting of this data under certain conditions, including for the purpose of triangulation with other quality and outcome data. The study identified an evidence gap in the assessment and interpretation of patient experience data at all levels, including the analysis and contextualisation of survey findings at the system level. Conclusion Patient experience surveys have potential for guiding practice level quality improvement but many barriers to their implementation remain. There is need for greater research and policy efforts to understand how this information can be used at the system level for improving Australian primary care.
Competing Interest Statement
Dr Levesque is a member of the Strategic Advisory Board of the Integrated Healthcare Journal. The authors declare no other conflicts of interest.
Funding Statement
The research reported has been conducted as part of the author's (HJS) doctoral study at the University of New South Wales. Funding was provided as part of her scholarship.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
De-identified data that support the findings of this study may be available on reasonable request from the corresponding author (hyun.song{at}unsw.edu.au). The data are not publicly available due to privacy or ethical restrictions.
